Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc.（AXSM）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
axsm · 股价预测 · 25 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 25 位华尔街分析师
Buy
25 位分析师
共识
评级分布
12 个月目标价
High
$302
Consensus
$256
+10.1% upside
Low
$200
Median: $259.5 · Last Close: $232.32
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$255.81
10.1% upside
High Target
$302
30.0%
Low Target
$200
-13.9%
Current Price
$232.32
as of today
Based on analyst price targets, the AXSM stock price prediction for the next 12 months ranges from $200 to $302. The consensus AXSM price forecast of $255.81 implies 10.1% upside from the current price of $232.32.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $232.45 | ↑ 0.06% |
1-day model range: $231.01–$233.9. Peak: $233.9 (+0.06%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $318 | +36.8% |
| 2028 | $394 | +69.6% |
| 2029 | $455 | +96.0% |
| 2030 | $501 | +115.8% |
| 2031 | — | +130.0% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AXSM · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-05 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-05 | Mizuho | Maintains | Outperform→Outperform |
| 2026-05-05 | Baird | Maintains | Outperform→Outperform |
| 2026-05-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-05 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2026-05-05 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-05-05 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-05 | Needham | Maintains | Buy→Buy |
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-04 | Jefferies | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Axsome Therapeutics, Inc. (AXSM) stock. Of the recent 215 rating actions, 4 were upgrades and 2 were downgrades. 25 analysts currently cover AXSM.
分析师推荐趋势
AXSM analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 10 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$984M
↓ 56.8% YoY
Revenue Next Year
$1.6B
↑ 60.5% YoY
EPS This Year
$-1.96
EPS Next Year
$5.52
↓ 381.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast AXSM EPS of $-1.96 for the current fiscal year, based on estimates from 12 analysts. The AXSM revenue forecast is $984M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AXSM 股价预测由两类独立数据源支撑：来自 25 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AXSM 的共识目标价为 $255.81（+10.1% 上行空间），分析师共识为 Buy。
AXSM 的短期预测（明日）为 $232.45（+0.06%）。 AXSM 对 2027 年的股价预测均值为 $318。 AXSM 对 2030 年的预测区间为 $467–$535。
Axsome Therapeutics, Inc. 在 NASDAQ 上市，代码 AXSM。AXSM 在 2027 年的整体展望偏积极，在覆盖分析师中约 96% 对应 Buy 共识。
常见问题
AXSM 预测 · 8 个问题根据 25 位华尔街分析师，AXSM 的 12 个月平均目标价为 $255.81，最高 $302.00、最低 $200.00。若有图表，中位目标价可在上方查看。相对当前价 $232.32，隐含约 +10.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.